References

1          Dupuytren G. De la rétraction des doigts par suite d'une affection de l'aponévrose palmaire. Compte rendu de la clinique chirurgicale de l'Hotel Dieu. J Hebdo Med Chir 1831; V: 349-65.
2          Hindocha S, McGrouther DA, Bayat A. Epidemiological Evaluation of Dupuytren's Disease Incidence and Prevalence Rates in Relation to Etiology. Hand (N Y) 2009.
3          Burge P. Genetics of Dupuytren's disease. Hand Clin 1999; 15: 63-71.
4          Murrell GA. The role of the fibroblast in Dupuytren's contracture. Hand Clin 1991; 7: 669-80; discussion 81.
5          Tomasek JJ, Vaughan MB, Haaksma CJ. Cellular structure and biology of Dupuytren's disease. Hand Clin 1999; 15: 21-34.
6          Murrell GA. Scientific comment. Basic science of Dupuytren's disease. Ann Chir Main Memb Super 1992; 11: 355-61.
7          Johnston P, Chojnowski AJ, Davidson RK et al. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease. J Hand Surg [Am] 2007; 32: 343-51.
8          Johnston P, Larson D, Clark IM et al. Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease. J Hand Surg [Am] 2008; 33: 1160-7.
9          Murrell GA, Francis MJ, Bromley L. Free radicals and Dupuytren's contracture. Br Med J (Clin Res Ed) 1987; 295: 1373-5.
10        Lermusiaux JL, Badois FJ, Lellouche H. Traitement des formes digitales pures de la maladie de Dupuytren par l'aponévrotomie à l'aiguille. In: La main rhumatologique 2002: Med-Line editions, 2002: 63-7.
11        Urban M, Feldberg L, Janssen A et al. Dupuytren's disease in children. J Hand Surg [Br] 1996; 21: 112-6.
12        Tubiana R. Evaluation of deformities in Dupuytren's disease. Ann Chir Main 1986; 5: 5-11.
13        Swartz WM, Lalonde DH. MOC-PS(SM) CME article: Dupuytren's disease. Plast Reconstr Surg 2008; 121: 1-10.
14        Lermusiaux JL, Lellouche H, Badois JF et al. How should Dupuytren's contracture be managed in 1997? Rev Rhum Engl Ed 1997; 64: 775-6.
15        Badois FJ, Lermusiaux JL, Masse C et al. [Non-surgical treatment of Dupuytren disease using needle fasciotomy]. Rev Rhum Ed Fr 1993; 60: 808-13.
16        Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am] 2007; 32: 767-74.
17        Hurst LC, Badalamente MA. Nonoperative treatment of Dupuytren's disease. Hand Clin 1999; 15: 97-107, vii.
18        Hindocha S, Stanley JK, Watson JS et al. Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings. Hand (N Y) 2008; 3: 80-6.
19        Makela EA, Jaroma H, Harju A et al. Dupuytren's contracture: the long-term results after day surgery. J Hand Surg [Br] 1991; 16: 272-4.
20        Prosser R, Conolly WB. Complications following surgical treatment for Dupuytren's contracture. J Hand Ther 1996; 9: 344-8.
21        Anwar MU, Al Ghazal SK, Boome RS. Results of surgical treatment of Dupuytren's disease in women: a review of 109 consecutive patients. J Hand Surg [Am] 2007; 32: 1423-8.
22        Lellouche H, Badois FJ, Teyssedou JP et al. Le traitement medical de la maladie de Dupuytren. Quoi de neuf en 2002 ? In: La main rhumatologique 2002: Med-Line editions, 2002.
23        Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg [Br] 2003; 28: 427-31.
24        Beaudreuil J, Lermusiaux JL, Teyssedou JP et al. Multi-aponévrotomie à l’aiguille pour maladie de Dupuytren : résultats à 18 mois d’une étude prospective. In: Congrès de la Société Française de Rhumatologie 2007. Paris, 2007: 0.90.
25        Lellouche H. [Dupuytren's contracture: surgery is no longer necessary]. Presse Med 2008; 37: 1779-81.
26        van Rijssen AL, Gerbrandy FS, Ter Linden H et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg [Am] 2006; 31: 717-25.
27        Lermusiaux JL, Badois FJ, Lellouche H. Le traitement des maladies associées à la maladie de Dupuytren. In: La main rhumatologique 2002: Med-Line editions, 2002.
28        Hindocha S, Stanley JK, Watson S et al. Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg [Am] 2006; 31: 1626-34.
29        Au-Yong IT, Wildin CJ, Dias JJ et al. A review of common practice in Dupuytren surgery. Tech Hand Up Extrem Surg 2005; 9: 178-87.
30        Clare T, Hazari A, Belcher H. Post-operative splinting to maintain full extension of the PIPJ after fasciectomy. Br J Plast Surg 2004; 57: 179-80.